Press Release: CRCM : Novel approach based on InVision® liquid biopsy platform predicts response to immune checkpoint inhibitors

Novel approach based on InVision ® liquid biopsy platform predicts response to immune checkpoint inhibitors New peer-reviewed publication outlines an approach...